Literature DB >> 11892964

Estimating the prevalence of dementia in elderly people: a comparison of the Canadian Study of Health and Aging and National Population Health Survey approaches.

V S Thomas1, S Darvesh, C MacKnight, K Rockwood.   

Abstract

The Canadian Study of Health and Aging (CSHA) and the National Population Health Survey (NPHS) collected data on the prevalence of dementia in differing fashions. The CSHA used a two-stage method with objective testing and expert judgment, and the NPHS used self-report and proxy data. The present report compares estimates of prevalence and the methodology for ascertainment in the two surveys. The more detailed approach of the CSHA offers the more valid means of estimating prevalence and providing data on subtypes, and can be used in naturalhistory studies. TheNPHSmeasures, including a self/proxy report of diagnosed dementia and a derived cognitive measure, are not sufficiently valid for useful inferences to be made. However, the NPHS method can be improved through supplementation with data on functional disability, providing age group-specific point estimates closer to the CSHA's estimates of cognitive impairment and dementia from the community sample. Future waves of the NPHS may wish to include objective cognitive function measures as a cost-efficient and more accurate method of estimating the prevalence of the dementia syndrome without attempting to estimate the prevalence of particular causes of that syndrome.

Entities:  

Mesh:

Year:  2001        PMID: 11892964     DOI: 10.1017/s1041610202008116

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  11 in total

Review 1.  The association of diabetes and dementia and possible implications for nondiabetic populations.

Authors:  Ramit Ravona-Springer; Michal Schnaider-Beeri
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

Review 2.  Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies.

Authors:  T Cukierman; H C Gerstein; J D Williamson
Journal:  Diabetologia       Date:  2005-11-08       Impact factor: 10.122

3.  Diabetes is associated with increased rate of cognitive decline in questionably demented elderly.

Authors:  Ramit Ravona-Springer; Xiaodong Luo; James Schmeidler; Michael Wysocki; Gerson Lesser; Michael Rapp; Karen Dahlman; Hillel Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Dement Geriatr Cogn Disord       Date:  2010-01-30       Impact factor: 2.959

Review 4.  Ghrelin receptor signaling: a promising therapeutic target for metabolic syndrome and cognitive dysfunction.

Authors:  Wei-na Cong; Erin Golden; Nick Pantaleo; Caitlin M White; Stuart Maudsley; Bronwen Martin
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

5.  Prevalence of cognitive impairment in individuals aged over 65 in an urban area: DERIVA study.

Authors:  Emiliano Rodríguez-Sánchez; Sara Mora-Simón; María C Patino-Alonso; Ricardo García-García; Alfonso Escribano-Hernández; Luis García-Ortiz; Ma Victoria Perea-Bartolomé; Manuel A Gómez-Marcos
Journal:  BMC Neurol       Date:  2011-11-17       Impact factor: 2.474

6.  Haptoglobin 1-1 genotype is associated with poorer cognitive functioning in the elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Elizabeth Guerrero-Berroa; Mary Sano; Rachel Preiss; Keren Koifman; Hadas Hoffman; Andrew Levy; Jeremy M Silverman; Michal Schnaider-Beeri
Journal:  Diabetes Care       Date:  2013-08-29       Impact factor: 19.112

Review 7.  Smart Homes for Elderly Healthcare-Recent Advances and Research Challenges.

Authors:  Sumit Majumder; Emad Aghayi; Moein Noferesti; Hamidreza Memarzadeh-Tehran; Tapas Mondal; Zhibo Pang; M Jamal Deen
Journal:  Sensors (Basel)       Date:  2017-10-31       Impact factor: 3.576

8.  Can cognitive enhancers reduce the risk of falls in older people with mild cognitive impairment? A protocol for a randomised controlled double blind trial.

Authors:  Manuel Montero-Odasso; Jennie L Wells; Michael J Borrie; Mark Speechley
Journal:  BMC Neurol       Date:  2009-08-12       Impact factor: 2.474

Review 9.  Mobility and Cognition in Seniors. Report from the 2008 Institute of Aging (CIHR) Mobility and Cognition Workshop.

Authors:  Manuel Montero-Odasso; Louis Bherer; Stephanie Studenski; Karen Gopaul; Afua Oteng-Amoako; Sarah Woolmore-Goodwin; Paul Stoole; Jennie Wells; Timothy Doherty; Aleksandra A Zecevic; David Galinsky; R Jane Rylett; Jeffrey Jutai; Susan Muir-Hunter; Mark Speechley; Richard Camicioli
Journal:  Can Geriatr J       Date:  2015-09-30

10.  Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).

Authors:  Manuel Montero-Odasso; Frederico Pieruccini-Faria; Robert Bartha; Sandra E Black; Elizabeth Finger; Morris Freedman; Barry Greenberg; David A Grimes; Robert A Hegele; Christopher Hudson; Peter W Kleinstiver; Anthony E Lang; Mario Masellis; Paula M McLaughlin; Douglas P Munoz; Stephen Strother; Richard H Swartz; Sean Symons; Maria Carmela Tartaglia; Lorne Zinman; Michael J Strong; William McIlroy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.